anastrozole
UkraineDrugs containing this active substance
-
The drug is intended for the treatment of postmenopausal women with advanced breast cancer (hormone receptor-positive), as well as for the adjuvant treatment of early-stage invasive breast cancer.
Form: tablets, film-coated
Active substance Dosage anastrozole 1 mg ATC: L02BG03
Manufacturer: Eugia Pharma Specialities Limited
-
The drug is prescribed to women in postmenopausal period for the treatment of advanced hormone receptor-positive breast cancer, as well as for adjuvant treatment of early-stage invasive breast cancer.
Form: tablets, film-coated
Active substance Dosage anastrozole 1 mg ATC: L02BG03
Manufacturer: Genepharm S.A.
-
The drug is used for the treatment of advanced breast cancer in postmenopausal women, as well as for the adjuvant treatment of early-stage invasive breast cancer (either as monotherapy or following long-term tamoxifen treatment).
Form: tablets, film-coated
Active substance Dosage anastrozole 1 mg ATC: L02BG03
Manufacturer: Salutas Pharma GmbH (manufacturing "in bulk", packaging, batch release; secondary packaging)
-
The drug is prescribed to women in the postmenopausal period for the treatment of advanced breast cancer (with positive hormone receptor status), as well as for the adjuvant treatment of early-stage invasive breast cancer.
Form: tablets, film-coated
Active substance Dosage anastrozole 1 mg ATC: L02BG03
Manufacturer: Synthon Hispania, S.L., Spain (manufacturing (full cycle), including batch release)
-
The drug is prescribed to women during postmenopause for adjuvant treatment of hormone receptor-positive invasive breast cancer (both in early stages and after tamoxifen therapy), as well as for the treatment of advanced hormone receptor-positive breast cancer.
Form: tablets, film-coated
Active substance Dosage anastrozole 1 mg ATC: L02BG03
Manufacturer: Hetero Labs Limited
-
The drug is prescribed to women in postmenopause for adjuvant treatment of hormone receptor-positive invasive breast cancer (both in early stages and after tamoxifen therapy), as well as for the treatment of advanced hormone receptor-positive breast cancer.
Form: tablets, film-coated
Active substance Dosage anastrozole 1 mg ATC: L02BG03
Manufacturer: AstraZeneca Pharmaceuticals LP (manufacturer of the medicinal product "in bulk")
-
The drug is indicated for women in postmenopause for the treatment of advanced hormone receptor-positive breast cancer, as well as for the adjuvant treatment of early-stage invasive breast cancer.
Form: tablets, film-coated
Active substance Dosage anastrozole 1 mg ATC: L02BG03
Manufacturer: PJSC Pharmaceutical Plant EGIS